Biogen: The Drive to Discover...The Drive to Deliver Home
SitemapContact Us
Research & Development

Research & Development

Biogen Research

Partnerships & Strategic Alliances

Product Pipeline


 Home

Product Pipeline

 Research Preclinical Phase I Phase II Phase III Regulatory Filing Approved Phase IV
AVONEX® (Interferon beta-1a)
MS-Open Label
MS-Monosymptomatic (CHAMPS)
MS-Secondary Progressive
MS-Combination Trials
AMEVIVE® (alefacept)
Psoriasis
ANTEGREN® (natalizumab)
MS
Crohn's disease
ADENTRI™ (adenosine A1 antagonist)
Congestive heart failure
Lymphotoxin Beta Receptor
Autoimmune diseases
Interferon Beta Gene Delivery
Cancer indications
VLA-1 mAb
Inflammation and Fibrosis
VLA-4 Inhibitor
Inflammation
LTBR mAb
Solid tumors

MS-Combination Trials

Biogen provides support for Phase IV investigator-run trials evaluating AVONEX® (Interferon beta-1a) in combination with other therapies.


About BIOGEN
BIOGEN in the Community
Products & Pipeline
Investor Relations
News & Media
Career Opportunities

Terms and Conditions of Use // Copyright © BIOGEN. Designed by Foster Design Group, Inc., and created and maintained by embarc. // Note Regarding Forward Looking Statements // Privacy Policy